Upcoming events

How will TAVI develop in various environments given the current economic and regulatory challenges

Chairpersons: V. Falk, P.W. Serruys

Learning Objectives

  • To understand the various TAVI penetrations in different parts of the word
  • To learn how TAVI cost-effectiveness is measured
  • To review the potential mechanisms of New technology introduction of TAVI in various health care environments

Presentations available when logged in:

  • Addressing the challenge of TAVI reimbursement
  • How can we make TAVI cost effective in lower risk patients?
  • Are head to head trials necessary for regulatory approval?
  • How can adjuvant TAVI therapies (ie. cerebral protection and closure devices) be approved for use?
  • Global variation in TAVI penetration: appropriate or inappropriate?